Pardes Biosciences Accounts Payable

Pardes Biosciences (PRDS) currently reports a accounts payable of $14K as of June 2023. That compares with $1.7M in the prior-year period — down 99.2% year over year. Use the charts on this page to explore Pardes Biosciences's accounts payable history and peer comparisons.

Pardes Biosciences's accounts payable decreased from $1.7M to $14K — a 99.2% year-over-year decrease (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Pardes Biosciences reported $14K in accounts payable as of June 2023. That compares with $1.7M in the prior-year period — down 99.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $14K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pardes Biosciences, and consider following PRDS for alerts when major investors trade the stock.